Cargando…
Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate Cancer
Prostate cancer (PCa) is a clinically heterogeneous disease and currently, accurate diagnostic and prognostic molecular biomarkers are lacking. This study aimed to identify novel DNA hypermethylation markers for PCa with future potential for blood-based testing. Accordingly, to search for genes spec...
Autores principales: | Bjerre, Marianne T., Strand, Siri H., Nørgaard, Maibritt, Kristensen, Helle, Rasmussen, Anne KI, Mortensen, Martin Mørck, Fredsøe, Jacob, Mouritzen, Peter, Ulhøi, Benedicte, Ørntoft, Torben, Borre, Michael, Sørensen, Karina D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429171/ https://www.ncbi.nlm.nih.gov/pubmed/30866497 http://dx.doi.org/10.3390/ijms20051173 |
Ejemplares similares
-
Epigenetic Analysis of Circulating Tumor DNA in Localized and Metastatic Prostate Cancer: Evaluation of Clinical Biomarker Potential
por: Bjerre, Marianne Trier, et al.
Publicado: (2020) -
Training and validation of a novel 4-miRNA ratio model (MiCaP) for prediction of postoperative outcome in prostate cancer patients
por: Schmidt, L, et al.
Publicado: (2018) -
Epigenetic silencing of MEIS2 in prostate cancer recurrence
por: Nørgaard, Maibritt, et al.
Publicado: (2019) -
Microbiota of the prostate tumor environment investigated by whole-transcriptome profiling
por: Salachan, Paul Vinu, et al.
Publicado: (2022) -
Biomarker potential of ST6GALNAC3 and ZNF660 promoter hypermethylation in prostate cancer tissue and liquid biopsies
por: Haldrup, Christa, et al.
Publicado: (2018)